Associated Papers
Cord Blood Transplantation Using Myeloablative Conditioning for Pediatric Advanced Myelodysplastic Syndrome in AMeD Syndrome With a Novel ADH5 Variant.
Morishita Y et al.
Pediatric Blood & Cancer, 2025
Characteristic phenotypes of ADH5/ALDH2 deficiency during childhood.
Matsumoto M et al.
European Journal of Medical Genetics, 2024
Two cases of AMeD syndrome with isochromosome 1q treated with allogeneic stem cell transplantation.
Kagajo M et al.
Leukemia Research Reports, 2024
Fanconi anemia and Aldehyde Degradation Deficiency Syndrome: Metabolism and DNA repair protect the genome and hematopoiesis from endogenous DNA damage.
Mu A et al.
Dna Repair, 2023
Inducing multiple nicks promotes interhomolog homologous recombination to correct heterozygous mutations in somatic cells.
Tomita A et al.
Nature Communications, 2023
Emerging bone marrow failure syndromes- new pieces to an unsolved puzzle.
Feurstein S
Frontiers in Oncology, 2023
Systematic analysis of inheritance pattern determination in genes that cause rare neurodevelopmental diseases.
Park S et al.
Frontiers in Genetics, 2022
Analysis of disease model iPSCs derived from patients with a novel Fanconi anemia-like IBMFS ADH5/ALDH2 deficiency.
Mu A et al.
Blood, 2021
Two Aldehyde Clearance Systems Are Essential to Prevent Lethal Formaldehyde Accumulation in Mice and Humans.
Dingler FA et al.
Molecular Cell, 2020
33147438 (PubMed )
Supplement: mmc1.pdf
Digenic mutations in ALDH2 and ADH5 impair formaldehyde clearance and cause a multisystem disorder, AMeD syndrome.
Oka Y et al.
Science Advances, 2020
Select a paper to view details